data_2eza_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eza _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.651 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.534 -0.913 . . . . 3.6299999999999999 108.534 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.5 mt -61.18 93.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.563 -0.711 . . . . 1.28 109.125 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.8 m -91.34 116.14 28.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.87 . . . . 1.24 109.461 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.37 -161.91 17.16 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.205 -1.958 . . . . 0.64000000000000001 108.205 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.505 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 21.3 mt -98.47 -6.77 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.235 -1.156 . . . . 1.3 109.095 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.6 tp 58.83 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.758 -0.777 . . . . 1.49 109.402 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.09 -54.13 4.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.971 -1.122 . . . . 1.1599999999999999 107.971 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.97 149.85 43.83 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.345 -0.984 . . . . 1.73 108.345 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -79.24 150.97 23.02 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.349 2.033 . . . . 0.72999999999999998 113.992 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.38 169.36 19.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.877 -1.689 . . . . 0.81000000000000005 108.877 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.8 mt -134.42 133.32 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.163 -1.198 . . . . 1.23 108.895 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.05 152.65 43.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.676 -0.64 . . . . 1.1599999999999999 109.478 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.3 m-85 -120.41 139.28 53.05 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.249 -1.019 . . . . 0.75 108.249 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.5 167.41 37.34 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 118.728 -1.701 . . . . 0.51000000000000001 111.017 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -82.86 152.07 25.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.462 -1.023 . . . . 2.3599999999999999 109.893 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -78.03 125.65 29.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.841 . . . . 1.21 110.925 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 tp -106.88 91.55 3.71 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.328 -1.36 . . . . 1.25 107.328 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 tp -81.14 126.39 31.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.942 -1.099 . . . . 1.3 110.581 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.2 mt -95.29 92.12 6.59 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.446 0.641 . . . . 1.27 109.716 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -93.09 159.42 15.3 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.626 -0.879 . . . . 2.54 108.626 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -130.51 139.79 50.5 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.296 -0.878 . . . . 2.6800000000000002 109.871 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.89 129.65 34.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.162 -1.051 . . . . 2.2000000000000002 108.162 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -64.95 137.87 58.01 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.995 -1.066 . . . . 2.0800000000000001 108.6 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.2 mt -88.27 135.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 1.3600000000000001 109.341 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.28 116.55 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.977 -0.749 . . . . 1.3700000000000001 108.977 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 79.5 mt -88.54 135.27 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 1.3600000000000001 109.567 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -89.81 122.21 32.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.398 -0.814 . . . . 1.5800000000000001 109.279 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -99.29 27.32 5.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.703 -0.851 . . . . 3.1000000000000001 108.703 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -82.94 144.73 29.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 2.8300000000000001 109.861 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -88.97 126.23 35.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 2.9199999999999999 108.819 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -87.05 175.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 122.012 0.911 . . . . 1.29 110.618 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.6 p -100.18 161.8 13.37 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.857 -0.794 . . . . 1.1899999999999999 108.857 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.45 -10.14 4.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.109 -0.994 . . . . 1.3100000000000001 109.421 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -83.93 -18.75 36.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 2.4399999999999999 109.734 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -108.81 -6.76 15.7 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.482 -0.761 . . . . 2.1899999999999999 109.598 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.06 -46.26 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.114 -0.991 . . . . 1.27 108.9 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -53.36 -35.89 60.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.383 -0.823 . . . . 1.54 109.395 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -70.88 -33.53 70.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 2.6800000000000002 110.724 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.45 -41.81 99.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.76 -1.212 . . . . 1.3 109.006 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 44' ' ' LEU . 91.1 t -60.55 -47.45 92.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.473 -0.767 . . . . 1.29 109.558 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -64.25 -40.69 96.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.111 -0.993 . . . . 1.5600000000000001 108.564 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -64.17 -35.87 82.2 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.72 -0.844 . . . . 3.3399999999999999 108.72 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -84.89 -52.66 5.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.492 -0.755 . . . . 0.93999999999999995 109.033 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 40' ' ' VAL . 47.3 tp -54.78 -62.84 1.4 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.719 -0.845 . . . . 1.5900000000000001 108.719 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 t -63.92 -35.67 81.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.77 -0.826 . . . . 1.27 108.77 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.7 -53.44 39.16 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 107.583 -2.207 . . . . 0.72999999999999998 107.583 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.521 ' NH1' ' OE2' ' A' ' 86' ' ' GLU . 37.9 ttp180 -49.15 -30.48 6.81 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.273 -1.134 . . . . 3.0600000000000001 108.803 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.74 -32.81 67.81 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.684 -1.228 . . . . 1.4199999999999999 107.684 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' GLY . 92.2 mttt -81.32 -59.9 2.47 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.408 0.623 . . . . 2.79 109.392 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.39 -37.37 47.86 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.348 -0.845 . . . . 1.29 109.248 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -65.43 -38.44 89.92 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.45 -0.945 . . . . 1.78 108.45 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' O ' ' OG1' ' A' ' 56' ' ' THR . . . -75.16 -33.92 61.55 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.312 0.577 . . . . 1.21 109.908 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.403 ' OE1' ' OD1' ' A' ' 140' ' ' ASN . 90.8 mt-30 -65.49 -66.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 2.1899999999999999 109.779 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 mt -54.17 -39.74 66.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 2.2200000000000002 109.33 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -56.66 -48.73 76.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.108 -1.071 . . . . 1.28 108.108 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 6.3 m -62.28 -37.91 87.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.547 -0.721 . . . . 1.21 109.425 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.5 mt -71.85 -33.42 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.413 -0.958 . . . . 1.24 108.413 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -56.7 -45.21 81.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.574 -0.704 . . . . 1.8 109.901 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.55 -28.56 65.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.176 -0.952 . . . . 1.25 109.646 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.433 ' O ' ' OG1' ' A' ' 64' ' ' THR . 54.2 mttm -70.28 -31.94 69.52 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.704 -1.221 . . . . 2.2200000000000002 107.704 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.44 75.96 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.764 -0.828 . . . . 1.1399999999999999 108.764 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -29.16 27.96 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.619 -1.277 . . . . 0.68000000000000005 110.087 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.62 -14.78 41.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.987 -1.302 . . . . 1.4199999999999999 109.136 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 72.5 m -98.03 -51.93 3.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.245 -0.909 . . . . 1.3100000000000001 111.432 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -105.55 -27.85 11.13 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.001 -1.062 . . . . 0.73999999999999999 109.596 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.91 168.57 13.14 Favored Glycine 0 N--CA 1.49 2.256 0 CA-C-O 122.972 1.318 . . . . 1.1299999999999999 111.215 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' LYS . 17.5 mt-10 -43.13 -56.99 3.13 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.792 1.775 . . . . 6.4000000000000004 115.792 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -46.4 -15.18 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.967 -1.083 . . . . 3.46 113.107 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 67' ' ' GLU . 8.8 mmtm -93.9 -17.92 22.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.517 -1.365 . . . . 2.5099999999999998 109.427 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -65.35 -34.46 78.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.05 -1.031 . . . . 1.6799999999999999 110.222 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.16 -29.92 71.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.199 -0.938 . . . . 1.27 109.825 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.2 mt -73.7 -44.21 52.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.088 -1.008 . . . . 1.3600000000000001 109.553 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -76.53 -23.32 53.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.94999999999999996 109.711 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.08 -43.8 90.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.085 -1.009 . . . . 1.3400000000000001 109.305 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.85 -32.15 66.77 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.94 -1.664 . . . . 0.54000000000000004 108.94 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.29 -22.68 66.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.399 -1.059 . . . . 2.1299999999999999 109.984 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mt -84.8 -36.42 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.741 -1.225 . . . . 1.24 108.124 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.1 ttt -58.79 -42.86 90.07 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.855 -0.794 . . . . 2.04 108.855 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.25 -41.48 99.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 1.24 109.063 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.8 tp -69.25 -43.27 74.3 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.353 -0.842 . . . . 1.25 109.369 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -85.08 9.24 15.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 1.29 109.843 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -49.72 122.57 6.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.0 . . . . 1.26 109.539 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.95 -23.3 65.95 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.518 -0.919 . . . . 1.3600000000000001 108.518 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.11 -53.88 7.66 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.584 -0.698 . . . . 2.29 109.229 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.9 mt -63.87 -14.25 51.75 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.732 -1.187 . . . . 1.1599999999999999 108.713 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' OE2' ' NH1' ' A' ' 47' ' ' ARG . 29.7 tt0 -77.04 -48.85 16.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.441 -0.787 . . . . 1.3600000000000001 109.867 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.17 -33.72 76.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.319 -0.863 . . . . 2.0600000000000001 109.944 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.97 -44.74 68.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 1.4299999999999999 109.122 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.5 mt -59.19 -58.4 7.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.212 -1.033 . . . . 1.1200000000000001 108.212 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.4 mt -45.42 -65.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 1.3 109.734 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -42.08 -54.85 3.42 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.463 -0.773 . . . . 1.26 110.82 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.3 mt -52.13 -56.32 15.27 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.048 -1.033 . . . . 1.3100000000000001 109.465 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -49.47 -44.73 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.96 -1.087 . . . . 1.1899999999999999 109.965 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -85.21 -35.99 21.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.03 -1.043 . . . . 2.3300000000000001 111.854 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.97 -35.69 25.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.698 -1.252 . . . . 1.5600000000000001 111.141 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -107.08 10.46 30.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.756 -1.215 . . . . 2.6000000000000001 110.029 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.0 m80 48.82 45.64 22.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.926 -1.109 . . . . 1.5700000000000001 108.94 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 13.8 mtt -98.55 150.6 21.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.611 -0.681 . . . . 1.6399999999999999 109.413 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.9 p -76.96 145.71 37.96 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.394 -0.816 . . . . 1.25 108.922 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.25 -25.39 5.58 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.996 -1.065 . . . . 1.1699999999999999 108.759 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.6 -47.22 33.56 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.247 -1.02 . . . . 2.1299999999999999 108.247 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.01 10.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.291 0.567 . . . . 1.2 109.899 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.32 -51.54 67.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.904 . . . . 1.1299999999999999 109.692 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.91 -33.87 65.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.177 -0.952 . . . . 1.1100000000000001 109.672 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -70.19 -35.77 74.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.086 -1.009 . . . . 1.9299999999999999 109.516 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.2 -58.51 8.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 1.3300000000000001 109.983 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.7 t -53.7 -50.43 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.986 -1.071 . . . . 1.25 109.378 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.86 -20.94 26.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.383 -0.823 . . . . 1.3100000000000001 109.484 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -72.29 -33.59 67.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.97 -1.081 . . . . 2.5099999999999998 109.35 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.54 -26.98 28.52 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.477 -1.344 . . . . 0.79000000000000004 112.432 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -66.74 -43.29 84.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.476 -1.603 . . . . 1.8700000000000001 109.025 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.72 -49.94 16.79 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.614 -0.679 . . . . 1.4199999999999999 109.291 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -60.33 -42.14 95.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 2.0299999999999998 110.3 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.14 82.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.835 -1.166 . . . . 1.45 110.295 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.8 mt -68.12 -27.85 66.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.68 -1.262 . . . . 1.6299999999999999 109.053 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -67.39 -20.18 65.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.975 -1.078 . . . . 1.8400000000000001 109.148 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.45 -5.43 57.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 1.6899999999999999 109.709 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 mt -86.89 148.24 25.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -0.962 . . . . 2.2400000000000002 109.001 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -97.41 56.07 1.31 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -0.822 . . . . 2.8599999999999999 109.168 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -149.85 119.04 6.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.93 -1.106 . . . . 2.1499999999999999 109.528 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.92 -18.14 42.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.475 -0.766 . . . . 3.21 110.947 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -75.47 -60.0 2.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.588 -1.32 . . . . 2.0099999999999998 109.331 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.2 mt -64.2 -26.93 68.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.971 -1.081 . . . . 1.8999999999999999 108.997 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 127' ' ' ALA . 25.5 tttt -68.86 -57.8 5.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 2.8599999999999999 109.328 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.23 -15.84 2.73 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.083 -1.047 . . . . 2.6200000000000001 108.302 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -75.77 -28.71 58.54 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.442 -1.688 . . . . 3.3599999999999999 106.442 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.17 -41.43 83.84 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.107 -1.072 . . . . 1.45 108.107 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.72 -38.78 84.04 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.413 -0.958 . . . . 1.49 108.413 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -69.49 -31.02 69.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.471 -0.768 . . . . 1.3799999999999999 109.359 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.27 -45.5 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 1.26 108.867 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -56.8 -39.32 73.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.949 -1.094 . . . . 3.7599999999999998 108.806 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -57.22 -35.96 70.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.39 -0.819 . . . . 1.3799999999999999 109.726 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.0 mt -69.09 -32.33 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.11 -0.994 . . . . 1.1699999999999999 109.306 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.34 -43.36 25.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.171 -1.572 . . . . 0.46999999999999997 109.171 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -51.99 -52.96 47.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.563 -0.963 . . . . 3.3999999999999999 109.032 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.426 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 33.1 mtt-85 -58.45 -47.22 84.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 3.3599999999999999 108.855 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.6 tp -54.21 -42.7 70.08 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.667 -0.645 . . . . 1.78 109.298 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.37 -56.7 15.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.98 . . . . 1.2 109.103 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -52.57 -20.79 3.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.796 . . . . 2.9300000000000002 110.438 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.464 ' N ' HD21 ' A' ' 140' ' ' ASN . 2.4 m120 -83.27 -38.12 22.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.95 -1.094 . . . . 1.51 109.331 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.2 mt -67.05 -41.51 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.241 -0.912 . . . . 1.3100000000000001 109.157 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.6 mt -87.04 3.54 45.62 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.459 -0.941 . . . . 1.47 108.459 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.35 20.87 11.25 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.175 -1.97 . . . . 0.95999999999999996 108.175 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.0 tp -49.93 156.13 0.79 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.489 -1.007 . . . . 1.71 108.944 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -68.12 146.22 53.65 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.114 -0.991 . . . . 3.6499999999999999 110.106 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.5 mt -108.95 140.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.398 -0.964 . . . . 1.6200000000000001 108.398 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.513 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.6 mp -76.51 120.93 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.044 -1.035 . . . . 1.9199999999999999 108.272 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.7 OUTLIER -95.19 87.89 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 2.0899999999999999 109.643 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.26 -23.55 37.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.852 . . . . 1.49 109.183 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -81.99 21.85 0.84 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 2.0699999999999998 109.589 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -134.0 31.07 3.61 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.169 -0.957 . . . . 1.5600000000000001 109.39 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 79.4 mt -74.17 150.9 7.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.415 -0.803 . . . . 1.6399999999999999 109.061 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -130.25 -12.95 4.0 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.329 -0.857 . . . . 2.6400000000000001 109.311 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -116.41 130.59 56.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.585 -0.697 . . . . 1.6000000000000001 109.405 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.59 123.96 20.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.373 -0.829 . . . . 1.4299999999999999 109.04 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.08 173.98 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 1.21 109.151 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.95 155.06 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.863 -1.162 . . . . 1.24 107.863 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.0 tp -106.28 120.58 42.22 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.176 -0.676 . . . . 1.2 109.176 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.04 131.29 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.196 -0.668 . . . . 1.21 109.196 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.55 152.6 14.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.413 -0.804 . . . . 1.21 110.15 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.38 84.85 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.478 -1.389 . . . . 1.29 107.612 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 162' ' ' ASP . 3.2 p30 -173.19 156.65 3.23 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.479 -0.934 . . . . 2.04 108.479 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.9 mt -124.86 138.64 54.25 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.317 -0.864 . . . . 1.23 109.665 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.0 p -93.87 151.7 40.04 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.505 -0.747 . . . . 1.3799999999999999 109.346 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -34.5 -45.79 0.49 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.646 2.23 . . . . 0.62 112.646 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 m -52.71 -62.83 1.4 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.297 -0.877 . . . . 1.1499999999999999 109.262 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -51.35 -41.34 60.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 1.3799999999999999 109.887 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.444 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 26.6 p -72.91 -26.71 61.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 1.1000000000000001 109.697 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.04 -25.21 58.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 1.21 110.118 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -107.32 -7.02 16.85 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.306 -0.871 . . . . 2.1400000000000001 110.095 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.32 152.57 20.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.957 -1.09 . . . . 1.3400000000000001 109.793 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.69 118.18 34.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.351 -0.843 . . . . 3.0899999999999999 109.361 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 17.5 mt -94.89 28.78 2.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.31 -0.869 . . . . 2.3100000000000001 109.551 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -122.64 -17.13 7.02 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.235 -0.916 . . . . 4.3300000000000001 109.492 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -120.42 -11.47 9.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.796 -0.565 . . . . 3.0699999999999998 109.631 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.3 t -79.58 154.13 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.233 -1.395 . . . . 1.26 107.233 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 10.5 tp -116.03 -9.24 11.76 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.585 -0.697 . . . . 1.8 109.514 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.74 173.01 36.87 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.096 -1.602 . . . . 0.5 109.096 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -128.27 123.96 35.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.606 -0.938 . . . . 0.51000000000000001 109.058 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.5 mt -127.13 118.76 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.074 -1.084 . . . . 1.1699999999999999 108.074 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 203' ' ' VAL . 16.6 p -142.24 150.54 41.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.334 -0.854 . . . . 1.21 110.956 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 0.3 OUTLIER -94.55 50.28 1.33 Allowed 'General case' 0 N--CA 1.507 2.415 0 O-C-N 120.718 -1.239 . . . . 2.3999999999999999 109.871 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -105.53 127.55 53.09 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.037 -1.039 . . . . 1.6200000000000001 110.009 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -22.98 -43.21 0.01 OUTLIER Glycine 0 N--CA 1.512 3.734 0 N-CA-C 111.891 -0.484 . . . . 2.0899999999999999 111.891 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 87.33 -20.66 25.29 Favored Glycine 0 N--CA 1.499 2.856 0 O-C-N 120.349 -1.677 . . . . 2.3799999999999999 114.256 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 185' ' ' GLY . 0.5 OUTLIER -45.66 -53.91 8.57 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 120.176 1.988 . . . . 5.5099999999999998 109.429 -178.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 24.2 p -137.52 45.42 2.18 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.376 -1.342 . . . . 4.3300000000000001 107.376 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.408 ' OG ' ' OG1' ' A' ' 190' ' ' THR . 32.4 t -78.08 127.09 31.78 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.8 0.809 . . . . 2.21 109.391 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.444 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 37.7 t60 -45.31 -35.06 3.25 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.124 -0.695 . . . . 1.0900000000000001 109.124 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.408 ' OG1' ' OG ' ' A' ' 188' ' ' SER . 0.1 OUTLIER -56.86 -62.07 2.0 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.825 -0.805 . . . . 2.3199999999999998 108.825 179.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.7 t -45.06 -46.9 11.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -0.815 . . . . 1.95 110.367 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.4 mt -55.07 -31.39 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.979 -1.075 . . . . 2.25 109.863 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 59.5 mtp -72.3 -55.38 7.25 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.524 -1.287 . . . . 1.23 107.524 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.33 -31.12 63.42 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.27 -0.877 . . . . 1.27 110.307 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -78.21 -51.58 9.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.122 -0.986 . . . . 3.2799999999999998 110.718 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.2 m -64.85 -34.83 79.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.977 -1.077 . . . . 1.22 109.617 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 199' ' ' LEU . 11.9 mt -89.63 0.15 57.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 1.26 109.019 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 52.66 6.74 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.878 . . . . 1.5900000000000001 111.366 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 197' ' ' LEU . 59.8 mt -66.5 166.72 16.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.623 -1.298 . . . . 1.3 108.638 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -85.95 138.12 5.77 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.928 1.752 . . . . 0.65000000000000002 111.389 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.88 173.54 12.58 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.709 -1.196 . . . . 1.1399999999999999 111.346 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.423 HG21 ' H ' ' A' ' 203' ' ' VAL . 53.8 mt -143.11 158.1 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.205 -1.776 . . . . 1.1799999999999999 106.205 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' THR . 1.6 m -139.3 -31.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.982 -1.073 . . . . 1.26 111.066 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.5 38.19 3.11 Favored Glycine 0 N--CA 1.495 2.576 0 O-C-N 120.658 -1.276 . . . . 0.66000000000000003 110.264 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.9 p -65.91 -25.85 67.34 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.798 -1.413 . . . . 1.3999999999999999 109.417 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 71.55 -96.13 0.64 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.755 -1.212 . . . . 1.1399999999999999 111.199 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.5 p -109.89 39.89 2.03 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.034 -1.274 . . . . 2.5600000000000001 113.563 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 4.0 t -73.62 -29.35 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 119.858 -1.776 . . . . 1.48 107.56 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 57.8 p -67.42 -12.91 61.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 1.3899999999999999 108.844 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.7 m -106.28 10.35 31.74 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.582 -0.895 . . . . 2.25 108.582 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -131.01 -14.36 3.47 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.574 -0.704 . . . . 2.9500000000000002 109.714 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.5 t -121.69 147.62 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.414 -0.804 . . . . 1.3300000000000001 110.032 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -111.77 178.67 4.24 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 103.99 -2.596 . . . . 2.4100000000000001 103.99 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 216' ' ' ASP . 17.7 p-10 -79.56 162.65 25.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 117.805 -1.558 . . . . 2.8100000000000001 106.819 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 72.84 -13.37 0.68 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.711 -0.618 . . . . 2.3399999999999999 109.957 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 214' ' ' ASN . 0.4 OUTLIER -57.66 142.65 44.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.764 -1.21 . . . . 1.9099999999999999 108.208 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -89.26 117.45 28.23 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.034 -1.041 . . . . 2.5499999999999998 109.03 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 26.1 mt -123.36 169.25 11.53 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.201 1.0 . . . . 1.3200000000000001 110.922 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 18.2 mt -141.09 116.3 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.101 -1.444 . . . . 1.25 107.101 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 52.2 tp -86.72 128.8 35.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.504 -0.924 . . . . 1.52 108.504 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.1 OUTLIER -97.0 -37.26 10.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.409 -0.807 . . . . 2.2999999999999998 109.236 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 41.15 20.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.662 -0.648 . . . . 1.1200000000000001 110.01 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.6 t -116.78 -54.02 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 106.059 -1.83 . . . . 1.26 106.059 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.65 10.47 32.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.466 -1.679 . . . . 2.8500000000000001 106.466 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.3 t30 54.0 60.19 3.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.399 -1.334 . . . . 2.0099999999999998 107.399 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -154.03 145.02 22.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.532 -0.73 . . . . 2.29 110.185 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.5 t -114.32 139.03 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.494 -0.928 . . . . 1.26 108.494 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -105.73 124.91 50.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.325 -0.86 . . . . 1.28 109.345 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.64 120.44 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.493 -0.755 . . . . 1.3600000000000001 109.668 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 53.47 70.17 1.91 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.371 -0.831 . . . . 2.25 110.044 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -86.16 151.68 9.48 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.888 2.392 . . . . 1.1000000000000001 112.159 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.2 p -73.97 155.36 38.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.174 -0.954 . . . . 2.3599999999999999 109.596 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -54.5 -41.31 69.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.409 -0.96 . . . . 3.4199999999999999 108.409 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.14 -42.3 39.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.789 -0.569 . . . . 3.23 110.156 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.86 -35.77 24.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.848 -1.158 . . . . 1.8 109.378 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 66.2 mt -67.8 -62.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 1.6499999999999999 109.064 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.66 -43.52 57.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.303 -0.873 . . . . 2.3999999999999999 109.792 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -63.66 -38.71 92.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.722 -0.612 . . . . 3.1600000000000001 110.145 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 243' ' ' GLN . 79.7 mtp -80.41 -43.38 21.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.021 -1.05 . . . . 1.5600000000000001 109.442 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -44.88 -42.29 7.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.187 -0.946 . . . . 3.2999999999999998 110.436 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.87 -64.42 1.01 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.894 -1.129 . . . . 1.9099999999999999 108.944 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.59 -55.72 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 2.3700000000000001 109.106 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 239' ' ' MET . 24.1 tm0? -44.21 -64.81 0.6 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.563 -0.71 . . . . 4.1200000000000001 110.728 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -58.98 -20.9 57.07 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.306 -0.872 . . . . 1.78 109.156 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 249' ' ' GLU . 23.1 tt0 -67.22 -26.25 66.5 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.869 -1.53 . . . . 2.6000000000000001 106.869 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 250' ' ' LYS . 59.0 t -72.98 -51.77 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.48 -0.933 . . . . 2.7400000000000002 108.48 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.12 68.25 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.516 -1.29 . . . . 2.6699999999999999 107.516 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.3 t -75.43 -36.94 60.68 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.404 -1.332 . . . . 3.1200000000000001 107.404 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 245' ' ' GLN . 74.0 tt0 -70.45 -17.38 62.99 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 106.122 -1.807 . . . . 4.1100000000000003 106.122 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 246' ' ' VAL . 30.1 tttp -83.8 -39.09 20.44 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.11 -1.811 . . . . 4.3399999999999999 106.11 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -65.43 -9.11 22.6 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 105.371 -2.085 . . . . 5.2000000000000002 105.371 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 250' ' ' LYS . 3.4 tt0 -70.79 -15.57 62.67 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.678 -2.712 . . . . 6.4100000000000001 103.678 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 256' ' ' LEU . 8.6 mt -78.51 -27.85 46.16 Favored 'General case' 0 C--O 1.204 -1.333 0 N-CA-C 104.132 -2.544 . . . . 8.0299999999999994 104.132 174.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.699 ' O ' ' NZ ' ' A' ' 257' ' ' LYS . . . -68.02 -37.14 81.04 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 102.748 -3.056 . . . . 8.75 102.748 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.698 ' C ' ' H ' ' A' ' 257' ' ' LYS . 10.2 mtpm? -73.75 16.86 0.18 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.534 -0.913 . . . . 10.56 108.534 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 253' ' ' LEU . 0.1 OUTLIER -73.94 39.16 0.11 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.982 -2.229 . . . . 11.52 104.982 179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.699 ' NZ ' ' O ' ' A' ' 254' ' ' ALA . 6.6 mttp -107.77 -18.05 13.92 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.927 -1.509 . . . . 12.81 106.927 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.641 ' N ' HH12 ' A' ' 259' ' ' ARG . 0.1 OUTLIER -71.97 -8.56 55.2 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.737 -2.32 . . . . 14.109999999999999 104.737 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.694 ' CB ' HH11 ' A' ' 259' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.286 0 N-CA-C 107.516 -1.29 . . . . 16.309999999999999 107.516 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.629 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.534 -0.913 . . . . 3.1499999999999999 108.534 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.5 mt -61.18 93.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.563 -0.711 . . . . 0.81999999999999995 109.125 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.8 m -91.34 116.14 28.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.87 . . . . 0.82999999999999996 109.461 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.37 -161.91 17.16 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.205 -1.958 . . . . 0.64000000000000001 108.205 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.505 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 21.3 mt -98.47 -6.77 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.235 -1.156 . . . . 0.76000000000000001 109.095 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.6 tp 58.83 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.758 -0.777 . . . . 0.81999999999999995 109.402 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.09 -54.13 4.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.971 -1.122 . . . . 0.62 107.971 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.97 149.85 43.83 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.345 -0.984 . . . . 1.25 108.345 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -79.24 150.97 23.02 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.349 2.033 . . . . 0.67000000000000004 113.992 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.85 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.38 169.36 19.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.877 -1.689 . . . . 0.81000000000000005 108.877 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 220' ' ' LEU . 61.8 mt -134.42 133.32 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.163 -1.198 . . . . 0.56999999999999995 108.895 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.05 152.65 43.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.676 -0.64 . . . . 0.5 109.478 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.3 m-85 -120.41 139.28 53.05 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.249 -1.019 . . . . 0.67000000000000004 108.249 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.5 167.41 37.34 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 118.728 -1.701 . . . . 0.47999999999999998 111.017 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -82.86 152.07 25.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.462 -1.023 . . . . 1.8 109.893 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -78.03 125.65 29.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.841 . . . . 0.55000000000000004 110.925 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 tp -106.88 91.55 3.71 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.328 -1.36 . . . . 0.64000000000000001 107.328 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 tp -81.14 126.39 31.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.942 -1.099 . . . . 0.69999999999999996 110.581 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 158' ' ' LEU . 27.2 mt -95.29 92.12 6.59 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.446 0.641 . . . . 0.66000000000000003 109.716 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -93.09 159.42 15.3 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.626 -0.879 . . . . 2.0099999999999998 108.626 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -130.51 139.79 50.5 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.296 -0.878 . . . . 2.6800000000000002 109.871 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.89 129.65 34.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.162 -1.051 . . . . 2.2000000000000002 108.162 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -64.95 137.87 58.01 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.995 -1.066 . . . . 2.0800000000000001 108.6 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.2 mt -88.27 135.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.81000000000000005 109.341 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.28 116.55 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.977 -0.749 . . . . 0.89000000000000001 108.977 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 79.5 mt -88.54 135.27 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.82999999999999996 109.567 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -89.81 122.21 32.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.398 -0.814 . . . . 1.5800000000000001 109.279 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -99.29 27.32 5.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.703 -0.851 . . . . 2.6000000000000001 108.703 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -82.94 144.73 29.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 2.3900000000000001 109.861 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -88.97 126.23 35.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 2.4500000000000002 108.819 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.43 HG12 ' H ' ' A' ' 31' ' ' ILE . 5.1 pt -87.05 175.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 122.012 0.911 . . . . 0.73999999999999999 110.618 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.6 p -100.18 161.8 13.37 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.857 -0.794 . . . . 0.85999999999999999 108.857 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.45 -10.14 4.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.109 -0.994 . . . . 0.79000000000000004 109.421 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -83.93 -18.75 36.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 2.4399999999999999 109.734 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -108.81 -6.76 15.7 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.482 -0.761 . . . . 1.53 109.598 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.06 -46.26 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.114 -0.991 . . . . 0.68000000000000005 108.9 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -53.36 -35.89 60.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.383 -0.823 . . . . 1.54 109.395 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -70.88 -33.53 70.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 2.3700000000000001 110.724 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.45 -41.81 99.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.76 -1.212 . . . . 1.3 109.006 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 44' ' ' LEU . 91.1 t -60.55 -47.45 92.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.473 -0.767 . . . . 0.73999999999999999 109.558 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -64.25 -40.69 96.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.111 -0.993 . . . . 1.5600000000000001 108.564 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -64.17 -35.87 82.2 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.72 -0.844 . . . . 2.7999999999999998 108.72 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -84.89 -52.66 5.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.492 -0.755 . . . . 0.76000000000000001 109.033 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 40' ' ' VAL . 47.3 tp -54.78 -62.84 1.4 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.719 -0.845 . . . . 1.0700000000000001 108.719 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.9 t -63.92 -35.67 81.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.77 -0.826 . . . . 0.93999999999999995 108.77 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.7 -53.44 39.16 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 107.583 -2.207 . . . . 0.72999999999999998 107.583 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.521 ' NH1' ' OE2' ' A' ' 86' ' ' GLU . 37.9 ttp180 -49.15 -30.48 6.81 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.273 -1.134 . . . . 2.52 108.803 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.74 -32.81 67.81 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.684 -1.228 . . . . 0.79000000000000004 107.684 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' GLY . 92.2 mttt -81.32 -59.9 2.47 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.408 0.623 . . . . 2.3100000000000001 109.392 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.39 -37.37 47.86 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.348 -0.845 . . . . 0.56999999999999995 109.248 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -65.43 -38.44 89.92 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.45 -0.945 . . . . 1.3300000000000001 108.45 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.16 -33.92 61.55 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.312 0.577 . . . . 0.59999999999999998 109.908 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.403 ' OE1' ' OD1' ' A' ' 140' ' ' ASN . 90.8 mt-30 -65.49 -66.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 1.49 109.779 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 mt -54.17 -39.74 66.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 1.6399999999999999 109.33 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -56.66 -48.73 76.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.108 -1.071 . . . . 1.28 108.108 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.3 m -62.28 -37.91 87.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.547 -0.721 . . . . 0.59999999999999998 109.425 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.5 mt -71.85 -33.42 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.413 -0.958 . . . . 0.59999999999999998 108.413 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -56.7 -45.21 81.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.574 -0.704 . . . . 1.24 109.901 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.55 -28.56 65.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.176 -0.952 . . . . 0.63 109.646 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' O ' ' OG1' ' A' ' 64' ' ' THR . 54.2 mttm -70.28 -31.94 69.52 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.704 -1.221 . . . . 1.7 107.704 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.44 75.96 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.764 -0.828 . . . . 0.5 108.764 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -29.16 27.96 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.619 -1.277 . . . . 0.68000000000000005 110.087 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.62 -14.78 41.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.987 -1.302 . . . . 1.4199999999999999 109.136 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 72.5 m -98.03 -51.93 3.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.245 -0.909 . . . . 0.75 111.432 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -105.55 -27.85 11.13 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.001 -1.062 . . . . 0.73999999999999999 109.596 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.91 168.57 13.14 Favored Glycine 0 N--CA 1.49 2.256 0 CA-C-O 122.972 1.318 . . . . 1.1299999999999999 111.215 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' LYS . 17.5 mt-10 -43.13 -56.99 3.13 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.792 1.775 . . . . 6.4000000000000004 115.792 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -46.4 -15.18 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.967 -1.083 . . . . 3.46 113.107 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 67' ' ' GLU . 8.8 mmtm -93.9 -17.92 22.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.517 -1.365 . . . . 2.0699999999999998 109.427 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -65.35 -34.46 78.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.05 -1.031 . . . . 1.6799999999999999 110.222 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.16 -29.92 71.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.199 -0.938 . . . . 0.68999999999999995 109.825 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.2 mt -73.7 -44.21 52.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.088 -1.008 . . . . 0.78000000000000003 109.553 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -76.53 -23.32 53.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.78000000000000003 109.711 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.08 -43.8 90.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.085 -1.009 . . . . 1.3400000000000001 109.305 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.85 -32.15 66.77 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.94 -1.664 . . . . 0.48999999999999999 108.94 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.29 -22.68 66.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.399 -1.059 . . . . 1.3100000000000001 109.984 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mt -84.8 -36.42 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.741 -1.225 . . . . 0.48999999999999999 108.124 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.1 ttt -58.79 -42.86 90.07 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.855 -0.794 . . . . 1.45 108.855 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.25 -41.48 99.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.59999999999999998 109.063 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.8 tp -69.25 -43.27 74.3 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.353 -0.842 . . . . 0.51000000000000001 109.369 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -85.08 9.24 15.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 1.29 109.843 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -49.72 122.57 6.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.0 . . . . 1.26 109.539 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.95 -23.3 65.95 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.518 -0.919 . . . . 1.3600000000000001 108.518 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.11 -53.88 7.66 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.584 -0.698 . . . . 2.29 109.229 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.9 mt -63.87 -14.25 51.75 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.732 -1.187 . . . . 0.5 108.713 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' OE2' ' NH1' ' A' ' 47' ' ' ARG . 29.7 tt0 -77.04 -48.85 16.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.441 -0.787 . . . . 1.3600000000000001 109.867 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.17 -33.72 76.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.319 -0.863 . . . . 1.5600000000000001 109.944 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.97 -44.74 68.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 1.4299999999999999 109.122 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.5 mt -59.19 -58.4 7.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.212 -1.033 . . . . 0.46999999999999997 108.212 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.4 mt -45.42 -65.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.68999999999999995 109.734 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -42.08 -54.85 3.42 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.463 -0.773 . . . . 0.65000000000000002 110.82 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.3 mt -52.13 -56.32 15.27 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.048 -1.033 . . . . 0.62 109.465 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -49.47 -44.73 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.96 -1.087 . . . . 0.54000000000000004 109.965 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -85.21 -35.99 21.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.03 -1.043 . . . . 1.8500000000000001 111.854 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.97 -35.69 25.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.698 -1.252 . . . . 1.5600000000000001 111.141 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -107.08 10.46 30.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.756 -1.215 . . . . 2.1000000000000001 110.029 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.0 m80 48.82 45.64 22.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.926 -1.109 . . . . 1.02 108.94 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 13.8 mtt -98.55 150.6 21.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.611 -0.681 . . . . 1.0800000000000001 109.413 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.9 p -76.96 145.71 37.96 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.394 -0.816 . . . . 0.60999999999999999 108.922 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.25 -25.39 5.58 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.996 -1.065 . . . . 0.46000000000000002 108.759 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.6 -47.22 33.56 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.247 -1.02 . . . . 2.1299999999999999 108.247 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.01 10.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.291 0.567 . . . . 0.52000000000000002 109.899 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.32 -51.54 67.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.904 . . . . 0.42999999999999999 109.692 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.91 -33.87 65.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.177 -0.952 . . . . 0.45000000000000001 109.672 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -70.19 -35.77 74.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.086 -1.009 . . . . 1.46 109.516 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.2 -58.51 8.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 1.3300000000000001 109.983 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.7 t -53.7 -50.43 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.986 -1.071 . . . . 0.57999999999999996 109.378 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.86 -20.94 26.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.383 -0.823 . . . . 0.73999999999999999 109.484 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -72.29 -33.59 67.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.97 -1.081 . . . . 2.5099999999999998 109.35 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.54 -26.98 28.52 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.477 -1.344 . . . . 0.72999999999999998 112.432 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -66.74 -43.29 84.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.476 -1.603 . . . . 1.23 109.025 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.72 -49.94 16.79 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.614 -0.679 . . . . 0.87 109.291 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -60.33 -42.14 95.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 1.6000000000000001 110.3 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.14 82.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.835 -1.166 . . . . 1.1399999999999999 110.295 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.8 mt -68.12 -27.85 66.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.68 -1.262 . . . . 1.1899999999999999 109.053 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -67.39 -20.18 65.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.975 -1.078 . . . . 1.8400000000000001 109.148 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.45 -5.43 57.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 1.6899999999999999 109.709 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 mt -86.89 148.24 25.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -0.962 . . . . 1.73 109.001 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -97.41 56.07 1.31 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -0.822 . . . . 2.8599999999999999 109.168 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -149.85 119.04 6.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.93 -1.106 . . . . 2.1499999999999999 109.528 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.92 -18.14 42.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.475 -0.766 . . . . 3.21 110.947 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -75.47 -60.0 2.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.588 -1.32 . . . . 1.6399999999999999 109.331 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.2 mt -64.2 -26.93 68.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.971 -1.081 . . . . 1.48 108.997 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 127' ' ' ALA . 25.5 tttt -68.86 -57.8 5.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 2.3999999999999999 109.328 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.23 -15.84 2.73 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.083 -1.047 . . . . 2.6200000000000001 108.302 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -75.77 -28.71 58.54 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.442 -1.688 . . . . 2.8799999999999999 106.442 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.17 -41.43 83.84 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.107 -1.072 . . . . 0.87 108.107 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.72 -38.78 84.04 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.413 -0.958 . . . . 0.90000000000000002 108.413 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -69.49 -31.02 69.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.471 -0.768 . . . . 1.3799999999999999 109.359 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.27 -45.5 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.59999999999999998 108.867 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -56.8 -39.32 73.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.949 -1.094 . . . . 3.2200000000000002 108.806 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -57.22 -35.96 70.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.39 -0.819 . . . . 1.3799999999999999 109.726 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.0 mt -69.09 -32.33 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.11 -0.994 . . . . 0.48999999999999999 109.306 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.34 -43.36 25.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.171 -1.572 . . . . 0.46000000000000002 109.171 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -51.99 -52.96 47.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.563 -0.963 . . . . 2.9399999999999999 109.032 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.451 ' HG2' HH11 ' A' ' 136' ' ' ARG . 33.1 mtt-85 -58.45 -47.22 84.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 2.5499999999999998 108.855 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.6 tp -54.21 -42.7 70.08 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.667 -0.645 . . . . 1.21 109.298 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.37 -56.7 15.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.98 . . . . 0.56000000000000005 109.103 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -52.57 -20.79 3.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.796 . . . . 2.4399999999999999 110.438 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 140' ' ' ASN . 2.4 m120 -83.27 -38.12 22.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.95 -1.094 . . . . 1.24 109.331 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.2 mt -67.05 -41.51 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.241 -0.912 . . . . 0.70999999999999996 109.157 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.6 mt -87.04 3.54 45.62 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.459 -0.941 . . . . 0.88 108.459 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.35 20.87 11.25 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.175 -1.97 . . . . 0.95999999999999996 108.175 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.0 tp -49.93 156.13 0.79 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.489 -1.007 . . . . 1.1000000000000001 108.944 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -68.12 146.22 53.65 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.114 -0.991 . . . . 3.3399999999999999 110.106 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.5 mt -108.95 140.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.398 -0.964 . . . . 1.1699999999999999 108.398 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.766 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.6 mp -76.51 120.93 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.044 -1.035 . . . . 1.3400000000000001 108.272 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.7 OUTLIER -95.19 87.89 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 2.0899999999999999 109.643 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.26 -23.55 37.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.852 . . . . 0.95999999999999996 109.183 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -81.99 21.85 0.84 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 1.5900000000000001 109.589 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -134.0 31.07 3.61 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.169 -0.957 . . . . 1.0900000000000001 109.39 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 79.4 mt -74.17 150.9 7.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.415 -0.803 . . . . 1.02 109.061 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -130.25 -12.95 4.0 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.329 -0.857 . . . . 2.1299999999999999 109.311 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -116.41 130.59 56.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.585 -0.697 . . . . 1.6000000000000001 109.405 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.59 123.96 20.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.373 -0.829 . . . . 1.4299999999999999 109.04 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.08 173.98 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.47999999999999998 109.151 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.95 155.06 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.863 -1.162 . . . . 0.54000000000000004 107.863 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 19' ' ' LEU . 15.0 tp -106.28 120.58 42.22 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.176 -0.676 . . . . 0.56999999999999995 109.176 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.04 131.29 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.196 -0.668 . . . . 0.52000000000000002 109.196 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.55 152.6 14.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.413 -0.804 . . . . 0.55000000000000004 110.15 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.38 84.85 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.478 -1.389 . . . . 0.65000000000000002 107.612 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 162' ' ' ASP . 3.2 p30 -173.19 156.65 3.23 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.479 -0.934 . . . . 2.04 108.479 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.9 mt -124.86 138.64 54.25 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.317 -0.864 . . . . 0.63 109.665 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.0 p -93.87 151.7 40.04 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.505 -0.747 . . . . 0.76000000000000001 109.346 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -34.5 -45.79 0.49 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.646 2.23 . . . . 0.58999999999999997 112.646 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 m -52.71 -62.83 1.4 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.297 -0.877 . . . . 0.65000000000000002 109.262 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -51.35 -41.34 60.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 1.3799999999999999 109.887 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.6 p -72.91 -26.71 61.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.48999999999999999 109.697 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.04 -25.21 58.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.55000000000000004 110.118 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 14.8 pt20 -107.32 -7.02 16.85 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.306 -0.871 . . . . 1.3999999999999999 110.095 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.32 152.57 20.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.957 -1.09 . . . . 0.65000000000000002 109.793 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.69 118.18 34.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.351 -0.843 . . . . 2.3799999999999999 109.361 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 17.5 mt -94.89 28.78 2.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.31 -0.869 . . . . 1.74 109.551 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -122.64 -17.13 7.02 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.235 -0.916 . . . . 3.8900000000000001 109.492 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -120.42 -11.47 9.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.796 -0.565 . . . . 2.6099999999999999 109.631 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.3 t -79.58 154.13 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.233 -1.395 . . . . 0.56999999999999995 107.233 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 10.5 tp -116.03 -9.24 11.76 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.585 -0.697 . . . . 1.1799999999999999 109.514 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.74 173.01 36.87 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.096 -1.602 . . . . 0.44 109.096 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -128.27 123.96 35.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.606 -0.938 . . . . 0.46000000000000002 109.058 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.5 mt -127.13 118.76 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.074 -1.084 . . . . 0.48999999999999999 108.074 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 203' ' ' VAL . 16.6 p -142.24 150.54 41.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.334 -0.854 . . . . 0.59999999999999998 110.956 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 0.3 OUTLIER -94.55 50.28 1.33 Allowed 'General case' 0 N--CA 1.507 2.415 0 O-C-N 120.718 -1.239 . . . . 2.3999999999999999 109.871 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -105.53 127.55 53.09 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.037 -1.039 . . . . 1.22 110.009 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -22.98 -43.21 0.01 OUTLIER Glycine 0 N--CA 1.512 3.734 0 N-CA-C 111.891 -0.484 . . . . 1.97 111.891 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 87.33 -20.66 25.29 Favored Glycine 0 N--CA 1.499 2.856 0 O-C-N 120.349 -1.677 . . . . 1.8799999999999999 114.256 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 185' ' ' GLY . 0.5 OUTLIER -45.66 -53.91 8.57 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 120.176 1.988 . . . . 5.0 109.429 -178.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 24.2 p -137.52 45.42 2.18 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.376 -1.342 . . . . 3.8500000000000001 107.376 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.4 t -78.08 127.09 31.78 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.8 0.809 . . . . 1.8200000000000001 109.391 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -45.31 -35.06 3.25 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.124 -0.695 . . . . 0.98999999999999999 109.124 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -62.07 2.0 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.825 -0.805 . . . . 1.73 108.825 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.7 t -45.06 -46.9 11.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -0.815 . . . . 1.47 110.367 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.4 mt -55.07 -31.39 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.979 -1.075 . . . . 1.6100000000000001 109.863 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 59.5 mtp -72.3 -55.38 7.25 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.524 -1.287 . . . . 1.0 107.524 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.33 -31.12 63.42 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.27 -0.877 . . . . 0.63 110.307 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -78.21 -51.58 9.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.122 -0.986 . . . . 2.7599999999999998 110.718 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.2 m -64.85 -34.83 79.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.977 -1.077 . . . . 0.76000000000000001 109.617 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 199' ' ' LEU . 11.9 mt -89.63 0.15 57.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.62 109.019 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 52.66 6.74 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.878 . . . . 1.5900000000000001 111.366 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.41 ' H ' ' C ' ' A' ' 197' ' ' LEU . 59.8 mt -66.5 166.72 16.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.623 -1.298 . . . . 0.70999999999999996 108.638 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -85.95 138.12 5.77 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.928 1.752 . . . . 0.53000000000000003 111.389 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.88 173.54 12.58 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.709 -1.196 . . . . 0.46999999999999997 111.346 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 53.8 mt -143.11 158.1 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.205 -1.776 . . . . 0.56999999999999995 106.205 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' THR . 1.6 m -139.3 -31.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.982 -1.073 . . . . 0.64000000000000001 111.066 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.5 38.19 3.11 Favored Glycine 0 N--CA 1.495 2.576 0 O-C-N 120.658 -1.276 . . . . 0.62 110.264 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.9 p -65.91 -25.85 67.34 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.798 -1.413 . . . . 0.93000000000000005 109.417 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 71.55 -96.13 0.64 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.755 -1.212 . . . . 1.1399999999999999 111.199 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.5 p -109.89 39.89 2.03 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.034 -1.274 . . . . 2.2999999999999998 113.563 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 4.0 t -73.62 -29.35 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 119.858 -1.776 . . . . 0.81999999999999995 107.56 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 57.8 p -67.42 -12.91 61.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.87 108.844 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.7 m -106.28 10.35 31.74 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.582 -0.895 . . . . 1.8 108.582 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -131.01 -14.36 3.47 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.574 -0.704 . . . . 2.3199999999999998 109.714 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.5 t -121.69 147.62 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.414 -0.804 . . . . 0.78000000000000003 110.032 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -111.77 178.67 4.24 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 103.99 -2.596 . . . . 1.96 103.99 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -79.56 162.65 25.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 117.805 -1.558 . . . . 2.21 106.819 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 72.84 -13.37 0.68 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.711 -0.618 . . . . 2.3399999999999999 109.957 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.66 142.65 44.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.764 -1.21 . . . . 1.9099999999999999 108.208 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -89.26 117.45 28.23 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.034 -1.041 . . . . 2.1099999999999999 109.03 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 26.1 mt -123.36 169.25 11.53 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.201 1.0 . . . . 0.76000000000000001 110.922 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 18.2 mt -141.09 116.3 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.101 -1.444 . . . . 0.59999999999999998 107.101 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 11' ' ' ILE . 52.2 tp -86.72 128.8 35.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.504 -0.924 . . . . 0.80000000000000004 108.504 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.1 OUTLIER -97.0 -37.26 10.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.409 -0.807 . . . . 2.2999999999999998 109.236 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.85 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 41.15 20.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.662 -0.648 . . . . 0.56000000000000005 110.01 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.6 t -116.78 -54.02 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 106.059 -1.83 . . . . 0.68999999999999995 106.059 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.65 10.47 32.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.466 -1.679 . . . . 2.21 106.466 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.3 t30 54.0 60.19 3.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.399 -1.334 . . . . 1.3100000000000001 107.399 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -154.03 145.02 22.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.532 -0.73 . . . . 1.8400000000000001 110.185 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.5 t -114.32 139.03 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.494 -0.928 . . . . 0.72999999999999998 108.494 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -105.73 124.91 50.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.325 -0.86 . . . . 0.85999999999999999 109.345 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.64 120.44 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.493 -0.755 . . . . 0.75 109.668 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 53.47 70.17 1.91 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.371 -0.831 . . . . 1.6000000000000001 110.044 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -86.16 151.68 9.48 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.888 2.392 . . . . 1.0700000000000001 112.159 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.2 p -73.97 155.36 38.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.174 -0.954 . . . . 1.8799999999999999 109.596 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -54.5 -41.31 69.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.409 -0.96 . . . . 2.7200000000000002 108.409 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.14 -42.3 39.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.789 -0.569 . . . . 3.23 110.156 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.86 -35.77 24.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.848 -1.158 . . . . 1.3300000000000001 109.378 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 66.2 mt -67.8 -62.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 1.1000000000000001 109.064 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.66 -43.52 57.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.303 -0.873 . . . . 2.3999999999999999 109.792 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -63.66 -38.71 92.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.722 -0.612 . . . . 2.6899999999999999 110.145 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 243' ' ' GLN . 79.7 mtp -80.41 -43.38 21.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.021 -1.05 . . . . 1.2 109.442 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -44.88 -42.29 7.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.187 -0.946 . . . . 2.8300000000000001 110.436 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.87 -64.42 1.01 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.894 -1.129 . . . . 1.51 108.944 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.59 -55.72 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 1.96 109.106 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 239' ' ' MET . 24.1 tm0? -44.21 -64.81 0.6 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.563 -0.71 . . . . 3.3500000000000001 110.728 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -58.98 -20.9 57.07 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.306 -0.872 . . . . 1.78 109.156 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 249' ' ' GLU . 23.1 tt0 -67.22 -26.25 66.5 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.869 -1.53 . . . . 2.23 106.869 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 250' ' ' LYS . 59.0 t -72.98 -51.77 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.48 -0.933 . . . . 2.3700000000000001 108.48 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.12 68.25 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.516 -1.29 . . . . 2.6699999999999999 107.516 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.3 t -75.43 -36.94 60.68 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.404 -1.332 . . . . 3.1200000000000001 107.404 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 245' ' ' GLN . 74.0 tt0 -70.45 -17.38 62.99 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 106.122 -1.807 . . . . 4.1100000000000003 106.122 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 246' ' ' VAL . 30.1 tttp -83.8 -39.09 20.44 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.11 -1.811 . . . . 4.3399999999999999 106.11 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 254' ' ' ALA . . . -65.43 -9.11 22.6 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 105.371 -2.085 . . . . 5.2000000000000002 105.371 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 250' ' ' LYS . 3.4 tt0 -70.79 -15.57 62.67 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.678 -2.712 . . . . 6.4100000000000001 103.678 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 256' ' ' LEU . 8.6 mt -78.51 -27.85 46.16 Favored 'General case' 0 C--O 1.204 -1.333 0 N-CA-C 104.132 -2.544 . . . . 7.8899999999999997 104.132 174.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.683 ' O ' ' NZ ' ' A' ' 257' ' ' LYS . . . -68.02 -37.14 81.04 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 102.748 -3.056 . . . . 8.75 102.748 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.692 ' C ' ' H ' ' A' ' 257' ' ' LYS . 10.2 mtpm? -73.75 16.86 0.18 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.534 -0.913 . . . . 10.35 108.534 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 253' ' ' LEU . 0.1 OUTLIER -73.94 39.16 0.11 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.982 -2.229 . . . . 11.52 104.982 179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.692 ' H ' ' C ' ' A' ' 255' ' ' LYS . 6.6 mttp -107.77 -18.05 13.92 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.927 -1.509 . . . . 12.6 106.927 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.665 ' N ' HH12 ' A' ' 259' ' ' ARG . 0.1 OUTLIER -71.97 -8.56 55.2 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.737 -2.32 . . . . 14.109999999999999 104.737 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.721 ' CB ' HH11 ' A' ' 259' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.286 0 N-CA-C 107.516 -1.29 . . . . 15.93 107.516 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.629 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.534 -0.913 . . . . 3.15 108.534 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.5 mt -61.18 93.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.563 -0.711 . . . . 0.82 109.125 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.8 m -91.34 116.14 28.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.87 . . . . 0.83 109.461 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.37 -161.91 17.16 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.205 -1.958 . . . . 0.64 108.205 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.505 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 21.3 mt -98.47 -6.77 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.235 -1.156 . . . . 0.76 109.095 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.6 tp 58.83 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.758 -0.777 . . . . 0.82 109.402 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.09 -54.13 4.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.971 -1.122 . . . . 0.62 107.971 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.97 149.85 43.83 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.345 -0.984 . . . . 1.25 108.345 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -79.24 150.97 23.02 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.349 2.033 . . . . 0.67 113.992 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.85 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.38 169.36 19.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.877 -1.689 . . . . 0.81 108.877 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 220' ' ' LEU . 61.8 mt -134.42 133.32 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.163 -1.198 . . . . 0.57 108.895 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.05 152.65 43.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.676 -0.64 . . . . 0.5 109.478 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.3 m-85 -120.41 139.28 53.05 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.249 -1.019 . . . . 0.67 108.249 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.5 167.41 37.34 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 118.728 -1.701 . . . . 0.48 111.017 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -82.86 152.07 25.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.462 -1.023 . . . . 1.8 109.893 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -78.03 125.65 29.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.841 . . . . 0.55 110.925 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 tp -106.88 91.55 3.71 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.328 -1.36 . . . . 0.64 107.328 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 tp -81.14 126.39 31.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.942 -1.099 . . . . 0.7 110.581 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 158' ' ' LEU . 27.2 mt -95.29 92.12 6.59 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.446 0.641 . . . . 0.66 109.716 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -93.09 159.42 15.3 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.626 -0.879 . . . . 2.01 108.626 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -130.51 139.79 50.5 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.296 -0.878 . . . . 2.68 109.871 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.89 129.65 34.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.162 -1.051 . . . . 2.2 108.162 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -64.95 137.87 58.01 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.995 -1.066 . . . . 2.08 108.6 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.2 mt -88.27 135.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.81 109.341 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.28 116.55 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.977 -0.749 . . . . 0.89 108.977 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 79.5 mt -88.54 135.27 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.83 109.567 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -89.81 122.21 32.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.398 -0.814 . . . . 1.58 109.279 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -99.29 27.32 5.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.703 -0.851 . . . . 2.6 108.703 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -82.94 144.73 29.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 2.39 109.861 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -88.97 126.23 35.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 2.45 108.819 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.43 HG12 ' H ' ' A' ' 31' ' ' ILE . 5.1 pt -87.05 175.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 122.012 0.911 . . . . 0.74 110.618 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.6 p -100.18 161.8 13.37 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.857 -0.794 . . . . 0.86 108.857 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.45 -10.14 4.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.109 -0.994 . . . . 0.79 109.421 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -83.93 -18.75 36.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 2.44 109.734 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.422 ' NE2' HG22 ' A' ' 31' ' ' ILE . 22.3 mt-30 -108.81 -6.76 15.7 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.482 -0.761 . . . . 1.53 109.598 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.06 -46.26 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.114 -0.991 . . . . 0.68 108.9 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -53.36 -35.89 60.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.383 -0.823 . . . . 1.54 109.395 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -70.88 -33.53 70.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 2.37 110.724 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.45 -41.81 99.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.76 -1.212 . . . . 1.3 109.006 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 44' ' ' LEU . 91.1 t -60.55 -47.45 92.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.473 -0.767 . . . . 0.74 109.558 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -64.25 -40.69 96.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.111 -0.993 . . . . 1.56 108.564 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -64.17 -35.87 82.2 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.72 -0.844 . . . . 2.8 108.72 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -84.89 -52.66 5.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.492 -0.755 . . . . 0.76 109.033 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 40' ' ' VAL . 47.3 tp -54.78 -62.84 1.4 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.719 -0.845 . . . . 1.07 108.719 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.9 t -63.92 -35.67 81.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.77 -0.826 . . . . 0.94 108.77 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.7 -53.44 39.16 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 107.583 -2.207 . . . . 0.73 107.583 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.521 ' NH1' ' OE2' ' A' ' 86' ' ' GLU . 37.9 ttp180 -49.15 -30.48 6.81 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.273 -1.134 . . . . 2.52 108.803 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.74 -32.81 67.81 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.684 -1.228 . . . . 0.79 107.684 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' GLY . 92.2 mttt -81.32 -59.9 2.47 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.408 0.623 . . . . 2.31 109.392 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.39 -37.37 47.86 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.348 -0.845 . . . . 0.57 109.248 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -65.43 -38.44 89.92 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.45 -0.945 . . . . 1.33 108.45 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.16 -33.92 61.55 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.312 0.577 . . . . 0.6 109.908 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.403 ' OE1' ' OD1' ' A' ' 140' ' ' ASN . 90.8 mt-30 -65.49 -66.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 1.49 109.779 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 mt -54.17 -39.74 66.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 1.64 109.33 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -56.66 -48.73 76.95 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.108 -1.071 . . . . 1.28 108.108 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.3 m -62.28 -37.91 87.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.547 -0.721 . . . . 0.6 109.425 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.5 mt -71.85 -33.42 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.413 -0.958 . . . . 0.6 108.413 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -56.7 -45.21 81.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.574 -0.704 . . . . 1.24 109.901 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.55 -28.56 65.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.176 -0.952 . . . . 0.63 109.646 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' O ' ' OG1' ' A' ' 64' ' ' THR . 54.2 mttm -70.28 -31.94 69.52 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.704 -1.221 . . . . 1.7 107.704 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.44 75.96 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.764 -0.828 . . . . 0.5 108.764 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -29.16 27.96 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.619 -1.277 . . . . 0.68 110.087 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.62 -14.78 41.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.987 -1.302 . . . . 1.42 109.136 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 72.5 m -98.03 -51.93 3.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.245 -0.909 . . . . 0.75 111.432 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -105.55 -27.85 11.13 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.001 -1.062 . . . . 0.74 109.596 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.91 168.57 13.14 Favored Glycine 0 N--CA 1.49 2.256 0 CA-C-O 122.972 1.318 . . . . 1.13 111.215 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 69' ' ' LYS . 17.5 mt-10 -43.13 -56.99 3.13 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.792 1.775 . . . . 6.4 115.792 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -46.4 -15.18 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.967 -1.083 . . . . 3.46 113.107 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 67' ' ' GLU . 8.8 mmtm -93.9 -17.92 22.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.517 -1.365 . . . . 2.07 109.427 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -65.35 -34.46 78.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.05 -1.031 . . . . 1.68 110.222 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.16 -29.92 71.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.199 -0.938 . . . . 0.69 109.825 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.2 mt -73.7 -44.21 52.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.088 -1.008 . . . . 0.78 109.553 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -76.53 -23.32 53.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.78 109.711 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.08 -43.8 90.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.085 -1.009 . . . . 1.34 109.305 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.85 -32.15 66.77 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.94 -1.664 . . . . 0.49 108.94 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.29 -22.68 66.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.399 -1.059 . . . . 1.31 109.984 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mt -84.8 -36.42 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.741 -1.225 . . . . 0.49 108.124 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.1 ttt -58.79 -42.86 90.07 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.855 -0.794 . . . . 1.45 108.855 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.25 -41.48 99.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.6 109.063 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.8 tp -69.25 -43.27 74.3 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.353 -0.842 . . . . 0.51 109.369 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -85.08 9.24 15.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 1.29 109.843 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -49.72 122.57 6.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.0 . . . . 1.26 109.539 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.95 -23.3 65.95 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.518 -0.919 . . . . 1.36 108.518 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.11 -53.88 7.66 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.584 -0.698 . . . . 2.29 109.229 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.9 mt -63.87 -14.25 51.75 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.732 -1.187 . . . . 0.5 108.713 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.521 ' OE2' ' NH1' ' A' ' 47' ' ' ARG . 29.7 tt0 -77.04 -48.85 16.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.441 -0.787 . . . . 1.36 109.867 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.17 -33.72 76.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.319 -0.863 . . . . 1.56 109.944 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.97 -44.74 68.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 1.43 109.122 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.5 mt -59.19 -58.4 7.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.212 -1.033 . . . . 0.47 108.212 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.4 mt -45.42 -65.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.69 109.734 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -42.08 -54.85 3.42 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.463 -0.773 . . . . 0.65 110.82 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.3 mt -52.13 -56.32 15.27 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.048 -1.033 . . . . 0.62 109.465 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -49.47 -44.73 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.96 -1.087 . . . . 0.54 109.965 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -85.21 -35.99 21.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.03 -1.043 . . . . 1.85 111.854 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.97 -35.69 25.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.698 -1.252 . . . . 1.56 111.141 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -107.08 10.46 30.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.756 -1.215 . . . . 2.1 110.029 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.0 m80 48.82 45.64 22.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.926 -1.109 . . . . 1.02 108.94 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 13.8 mtt -98.55 150.6 21.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.611 -0.681 . . . . 1.08 109.413 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.9 p -76.96 145.71 37.96 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.394 -0.816 . . . . 0.61 108.922 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.25 -25.39 5.58 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.996 -1.065 . . . . 0.46 108.759 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.6 -47.22 33.56 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.247 -1.02 . . . . 2.13 108.247 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.01 10.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.291 0.567 . . . . 0.52 109.899 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.32 -51.54 67.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.904 . . . . 0.43 109.692 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.91 -33.87 65.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.177 -0.952 . . . . 0.45 109.672 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -70.19 -35.77 74.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.086 -1.009 . . . . 1.46 109.516 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.2 -58.51 8.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 1.33 109.983 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.7 t -53.7 -50.43 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.986 -1.071 . . . . 0.58 109.378 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.86 -20.94 26.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.383 -0.823 . . . . 0.74 109.484 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -72.29 -33.59 67.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.97 -1.081 . . . . 2.51 109.35 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.54 -26.98 28.52 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.477 -1.344 . . . . 0.73 112.432 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -66.74 -43.29 84.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.476 -1.603 . . . . 1.23 109.025 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.72 -49.94 16.79 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.614 -0.679 . . . . 0.87 109.291 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -60.33 -42.14 95.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 1.6 110.3 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.14 82.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.835 -1.166 . . . . 1.14 110.295 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.8 mt -68.12 -27.85 66.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.68 -1.262 . . . . 1.19 109.053 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -67.39 -20.18 65.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.975 -1.078 . . . . 1.84 109.148 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.45 -5.43 57.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 1.69 109.709 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 mt -86.89 148.24 25.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -0.962 . . . . 1.73 109.001 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -97.41 56.07 1.31 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -0.822 . . . . 2.86 109.168 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -149.85 119.04 6.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.93 -1.106 . . . . 2.15 109.528 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.92 -18.14 42.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.475 -0.766 . . . . 3.21 110.947 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -75.47 -60.0 2.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.588 -1.32 . . . . 1.64 109.331 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.2 mt -64.2 -26.93 68.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.971 -1.081 . . . . 1.48 108.997 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 127' ' ' ALA . 25.5 tttt -68.86 -57.8 5.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 2.4 109.328 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.23 -15.84 2.73 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.083 -1.047 . . . . 2.62 108.302 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -75.77 -28.71 58.54 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.442 -1.688 . . . . 2.88 106.442 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.17 -41.43 83.84 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.107 -1.072 . . . . 0.87 108.107 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.72 -38.78 84.04 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.413 -0.958 . . . . 0.9 108.413 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -69.49 -31.02 69.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.471 -0.768 . . . . 1.38 109.359 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.27 -45.5 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.6 108.867 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -56.8 -39.32 73.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.949 -1.094 . . . . 3.22 108.806 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -57.22 -35.96 70.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.39 -0.819 . . . . 1.38 109.726 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.0 mt -69.09 -32.33 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.11 -0.994 . . . . 0.49 109.306 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.34 -43.36 25.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.171 -1.572 . . . . 0.46 109.171 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -51.99 -52.96 47.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.563 -0.963 . . . . 2.94 109.032 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.451 HH11 ' HG2' ' A' ' 136' ' ' ARG . 33.1 mtt-85 -58.45 -47.22 84.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 2.55 108.855 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.6 tp -54.21 -42.7 70.08 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.667 -0.645 . . . . 1.21 109.298 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.37 -56.7 15.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.98 . . . . 0.56 109.103 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -52.57 -20.79 3.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.796 . . . . 2.44 110.438 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 140' ' ' ASN . 2.4 m120 -83.27 -38.12 22.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.95 -1.094 . . . . 1.24 109.331 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.2 mt -67.05 -41.51 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.241 -0.912 . . . . 0.71 109.157 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.6 mt -87.04 3.54 45.62 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.459 -0.941 . . . . 0.88 108.459 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.35 20.87 11.25 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.175 -1.97 . . . . 0.96 108.175 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.0 tp -49.93 156.13 0.79 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.489 -1.007 . . . . 1.1 108.944 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -68.12 146.22 53.65 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.114 -0.991 . . . . 3.34 110.106 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.5 mt -108.95 140.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.398 -0.964 . . . . 1.17 108.398 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.766 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.6 mp -76.51 120.93 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.044 -1.035 . . . . 1.34 108.272 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.7 OUTLIER -95.19 87.89 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 2.09 109.643 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.26 -23.55 37.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.852 . . . . 0.96 109.183 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -81.99 21.85 0.84 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 1.59 109.589 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -134.0 31.07 3.61 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.169 -0.957 . . . . 1.09 109.39 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 79.4 mt -74.17 150.9 7.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.415 -0.803 . . . . 1.02 109.061 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -130.25 -12.95 4.0 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.329 -0.857 . . . . 2.13 109.311 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -116.41 130.59 56.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.585 -0.697 . . . . 1.6 109.405 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.59 123.96 20.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.373 -0.829 . . . . 1.43 109.04 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.08 173.98 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.48 109.151 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.95 155.06 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.863 -1.162 . . . . 0.54 107.863 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 19' ' ' LEU . 15.0 tp -106.28 120.58 42.22 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.176 -0.676 . . . . 0.57 109.176 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.04 131.29 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.196 -0.668 . . . . 0.52 109.196 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.55 152.6 14.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.413 -0.804 . . . . 0.55 110.15 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.38 84.85 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.478 -1.389 . . . . 0.65 107.612 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 162' ' ' ASP . 3.2 p30 -173.19 156.65 3.23 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.479 -0.934 . . . . 2.04 108.479 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.9 mt -124.86 138.64 54.25 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.317 -0.864 . . . . 0.63 109.665 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.0 p -93.87 151.7 40.04 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.505 -0.747 . . . . 0.76 109.346 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -34.5 -45.79 0.49 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.646 2.23 . . . . 0.59 112.646 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 m -52.71 -62.83 1.4 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.297 -0.877 . . . . 0.65 109.262 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -51.35 -41.34 60.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 1.38 109.887 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.6 p -72.91 -26.71 61.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.49 109.697 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.04 -25.21 58.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.55 110.118 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 14.8 pt20 -107.32 -7.02 16.85 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.306 -0.871 . . . . 1.4 110.095 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.32 152.57 20.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.957 -1.09 . . . . 0.65 109.793 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.69 118.18 34.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.351 -0.843 . . . . 2.38 109.361 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 17.5 mt -94.89 28.78 2.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.31 -0.869 . . . . 1.74 109.551 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -122.64 -17.13 7.02 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.235 -0.916 . . . . 3.89 109.492 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -120.42 -11.47 9.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.796 -0.565 . . . . 2.61 109.631 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.3 t -79.58 154.13 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.233 -1.395 . . . . 0.57 107.233 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 10.5 tp -116.03 -9.24 11.76 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.585 -0.697 . . . . 1.18 109.514 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.74 173.01 36.87 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.096 -1.602 . . . . 0.44 109.096 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -128.27 123.96 35.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.606 -0.938 . . . . 0.46 109.058 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.5 mt -127.13 118.76 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.074 -1.084 . . . . 0.49 108.074 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 203' ' ' VAL . 16.6 p -142.24 150.54 41.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.334 -0.854 . . . . 0.6 110.956 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 0.3 OUTLIER -94.55 50.28 1.33 Allowed 'General case' 0 N--CA 1.507 2.415 0 O-C-N 120.718 -1.239 . . . . 2.4 109.871 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -105.53 127.55 53.09 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.037 -1.039 . . . . 1.22 110.009 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -22.98 -43.21 0.01 OUTLIER Glycine 0 N--CA 1.512 3.734 0 N-CA-C 111.891 -0.484 . . . . 1.97 111.891 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 87.33 -20.66 25.29 Favored Glycine 0 N--CA 1.499 2.856 0 O-C-N 120.349 -1.677 . . . . 1.88 114.256 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 185' ' ' GLY . 0.5 OUTLIER -45.66 -53.91 8.57 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 120.176 1.988 . . . . 5.0 109.429 -178.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 24.2 p -137.52 45.42 2.18 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.376 -1.342 . . . . 3.85 107.376 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.4 t -78.08 127.09 31.78 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.8 0.809 . . . . 1.82 109.391 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -45.31 -35.06 3.25 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.124 -0.695 . . . . 0.99 109.124 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -62.07 2.0 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.825 -0.805 . . . . 1.73 108.825 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.7 t -45.06 -46.9 11.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -0.815 . . . . 1.47 110.367 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.4 mt -55.07 -31.39 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.979 -1.075 . . . . 1.61 109.863 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 59.5 mtp -72.3 -55.38 7.25 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.524 -1.287 . . . . 1.0 107.524 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.33 -31.12 63.42 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.27 -0.877 . . . . 0.63 110.307 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -78.21 -51.58 9.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.122 -0.986 . . . . 2.76 110.718 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.2 m -64.85 -34.83 79.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.977 -1.077 . . . . 0.76 109.617 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 199' ' ' LEU . 11.9 mt -89.63 0.15 57.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.62 109.019 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 52.66 6.74 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.878 . . . . 1.59 111.366 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.41 ' H ' ' C ' ' A' ' 197' ' ' LEU . 59.8 mt -66.5 166.72 16.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.623 -1.298 . . . . 0.71 108.638 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -85.95 138.12 5.77 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.928 1.752 . . . . 0.53 111.389 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.88 173.54 12.58 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.709 -1.196 . . . . 0.47 111.346 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 53.8 mt -143.11 158.1 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.205 -1.776 . . . . 0.57 106.205 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' THR . 1.6 m -139.3 -31.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.982 -1.073 . . . . 0.64 111.066 -177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.5 38.19 3.11 Favored Glycine 0 N--CA 1.495 2.576 0 O-C-N 120.658 -1.276 . . . . 0.62 110.264 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 36.9 p -65.91 -25.85 67.34 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.798 -1.413 . . . . 0.93 109.417 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 71.55 -96.13 0.64 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.755 -1.212 . . . . 1.14 111.199 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.5 p -109.89 39.89 2.03 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.034 -1.274 . . . . 2.3 113.563 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 4.0 t -73.62 -29.35 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 119.858 -1.776 . . . . 0.82 107.56 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 57.8 p -67.42 -12.91 61.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.87 108.844 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.7 m -106.28 10.35 31.74 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.582 -0.895 . . . . 1.8 108.582 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -131.01 -14.36 3.47 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.574 -0.704 . . . . 2.32 109.714 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.5 t -121.69 147.62 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.414 -0.804 . . . . 0.78 110.032 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -111.77 178.67 4.24 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 103.99 -2.596 . . . . 1.96 103.99 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -79.56 162.65 25.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 117.805 -1.558 . . . . 2.21 106.819 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 72.84 -13.37 0.68 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.711 -0.618 . . . . 2.34 109.957 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.66 142.65 44.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.764 -1.21 . . . . 1.91 108.208 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -89.26 117.45 28.23 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.034 -1.041 . . . . 2.11 109.03 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 26.1 mt -123.36 169.25 11.53 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.201 1.0 . . . . 0.76 110.922 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 18.2 mt -141.09 116.3 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.101 -1.444 . . . . 0.6 107.101 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 11' ' ' ILE . 52.2 tp -86.72 128.8 35.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.504 -0.924 . . . . 0.8 108.504 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.1 OUTLIER -97.0 -37.26 10.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.409 -0.807 . . . . 2.3 109.236 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.85 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 41.15 20.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.662 -0.648 . . . . 0.56 110.01 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.6 t -116.78 -54.02 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 106.059 -1.83 . . . . 0.69 106.059 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.65 10.47 32.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.466 -1.679 . . . . 2.21 106.466 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.3 t30 54.0 60.19 3.78 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.399 -1.334 . . . . 1.31 107.399 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -154.03 145.02 22.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.532 -0.73 . . . . 1.84 110.185 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.5 t -114.32 139.03 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.494 -0.928 . . . . 0.73 108.494 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -105.73 124.91 50.33 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.325 -0.86 . . . . 0.86 109.345 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.64 120.44 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.493 -0.755 . . . . 0.75 109.668 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 53.47 70.17 1.91 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.371 -0.831 . . . . 1.6 110.044 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -86.16 151.68 9.48 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.888 2.392 . . . . 1.07 112.159 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.2 p -73.97 155.36 38.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.174 -0.954 . . . . 1.88 109.596 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -54.5 -41.31 69.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.409 -0.96 . . . . 2.72 108.409 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.14 -42.3 39.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.789 -0.569 . . . . 3.23 110.156 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.86 -35.77 24.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.848 -1.158 . . . . 1.33 109.378 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 66.2 mt -67.8 -62.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 1.1 109.064 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.66 -43.52 57.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.303 -0.873 . . . . 2.4 109.792 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -63.66 -38.71 92.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.722 -0.612 . . . . 2.69 110.145 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 243' ' ' GLN . 79.7 mtp -80.41 -43.38 21.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.021 -1.05 . . . . 1.2 109.442 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -44.88 -42.29 7.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.187 -0.946 . . . . 2.83 110.436 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.87 -64.42 1.01 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.894 -1.129 . . . . 1.51 108.944 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.59 -55.72 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.896 . . . . 1.96 109.106 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 239' ' ' MET . 24.1 tm0? -44.21 -64.81 0.6 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.563 -0.71 . . . . 3.35 110.728 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -58.98 -20.9 57.07 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.306 -0.872 . . . . 1.78 109.156 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 249' ' ' GLU . 23.1 tt0 -67.22 -26.25 66.5 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.869 -1.53 . . . . 2.23 106.869 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 250' ' ' LYS . 59.0 t -72.98 -51.77 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.48 -0.933 . . . . 2.37 108.48 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.12 68.25 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.516 -1.29 . . . . 2.67 107.516 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.3 t -75.43 -36.94 60.68 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.404 -1.332 . . . . 3.12 107.404 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 245' ' ' GLN . 74.0 tt0 -70.45 -17.38 62.99 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 106.122 -1.807 . . . . 4.11 106.122 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 246' ' ' VAL . 30.1 tttp -83.8 -39.09 20.44 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.11 -1.811 . . . . 4.34 106.11 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 254' ' ' ALA . . . -65.43 -9.11 22.6 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 105.371 -2.085 . . . . 5.2 105.371 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 250' ' ' LYS . 3.4 tt0 -70.79 -15.57 62.67 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 103.678 -2.712 . . . . 6.41 103.678 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 256' ' ' LEU . 8.6 mt -78.51 -27.85 46.16 Favored 'General case' 0 C--O 1.204 -1.333 0 N-CA-C 104.132 -2.544 . . . . 7.89 104.132 174.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.683 ' O ' ' NZ ' ' A' ' 257' ' ' LYS . . . -68.02 -37.14 81.04 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 102.748 -3.056 . . . . 8.75 102.748 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.692 ' C ' ' H ' ' A' ' 257' ' ' LYS . 10.2 mtpm? -73.75 16.86 0.18 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.534 -0.913 . . . . 10.35 108.534 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 253' ' ' LEU . 0.1 OUTLIER -73.94 39.16 0.11 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 104.982 -2.229 . . . . 11.52 104.982 179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.692 ' H ' ' C ' ' A' ' 255' ' ' LYS . 6.6 mttp -107.77 -18.05 13.92 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.927 -1.509 . . . . 12.6 106.927 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.665 ' N ' HH12 ' A' ' 259' ' ' ARG . 0.1 OUTLIER -71.97 -8.56 55.2 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.737 -2.32 . . . . 14.11 104.737 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.721 HH11 ' CB ' ' A' ' 259' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.286 0 N-CA-C 107.516 -1.29 . . . . 15.93 107.516 -179.73 . . . . . . . . 2 2 . 1 stop_ save_